(Circulation. 1995;92:1743-1748.)
© 1995 American Heart Association, Inc.
Articles |
Previous Aspirin Use May Attenuate the Severity of the Manifestation of Acute Ischemic Syndromes
From the Service of Cardiology, Hospital General Universitari Vall d'Hebron, Barcelona, Spain, and the Department of Medicine, Montreal Heart Institute, Montreal, Quebec, Canada.
Correspondence to David Garcia-Dorado, MD, Service of Cardiology, Hospital General Universitari Vall d'Hebron, Pg. Vall d'Hebron, 119-129, 08035 Barcelona, Spain.
Background The present study was designed to investigate whether the prior use of aspirin could influence the severity of the manifestation of acute coronary artery syndromes, given the well-documented observations that aspirin can prevent myocardial infarction, stroke, and death in cardiovascular disease.
Methods and Results A series of 539 consecutive patients admitted to the Coronary Care Unit of a General Hospital was carefully characterized in a study with an ambidirectional design, with regard to previous medical history, aspirin use, and subsequent hospital diagnosis. Among the 214 patients previously taking aspirin, the hospital diagnosis was myocardial infarction in 24% and unstable angina in 76% compared with 54% and 46%, respectively, among the 325 not taking aspirin (P<.0001), for a reduction in the odds ratio of myocardial infarction with aspirin of 72% (95% CI, 59% to 90%). The decrease in odds was homogeneous in all subsets studied and independent of age, sex, previous angina, or previous myocardial infarction. The myocardial infarction was of a Q-wave type in 62% of aspirin users compared with 76% of nonusers (P<.05). By multivariate analysis, previous aspirin use was a strong predictor of unstable angina versus myocardial infarction and the only independent predictor of non–Q-wave versus Q-wave myocardial infarction.
Conclusions This study, thus, suggests a shift to less severe manifestation of acute coronary syndromes with aspirin use, implying that the failure of the drug in many patients with an acute coronary syndrome is only partial and that aspirin has the potential of attenuating the severity of the underlying acute thrombotic disease process.
Key Words: angina • myocardial infarction • coronary disease • aspirin
This article has been cited by other articles:
 |
|
 |
|
  E. L. Portnay, J. M. Foody, S. S. Rathore, Y. Wang, F. A. Masoudi, J. P. Curtis, and H. M. Krumholz Prior Aspirin Use and Outcomes in Elderly Patients Hospitalized With Acute Myocardial Infarction J. Am. Coll. Cardiol., September 20, 2005; 46(6): 967 - 974. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Labinaz, J. Mathias, K. Pieper, C. B. Granger, A. M. Lincoff, D. J. Moliterno, F. Van de Werf, J. Simes, H. D. White, M. L. Simoons, et al. Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials Eur. Heart J., January 2, 2005; 26(2): 128 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.P. Collet, G. Montalescot, B. Blanchet, M.L. Tanguy, J.L. Golmard, R. Choussat, F. Beygui, L. Payot, N. Vignolles, J.P. Metzger, et al. Impact of Prior Use or Recent Withdrawal of Oral Antiplatelet Agents on Acute Coronary Syndromes Circulation, October 19, 2004; 110(16): 2361 - 2367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Wilterdink, B. Bendixen, H. P. Adams Jr, R. F. Woolson, W. R. Clarke, and M. D. Hansen Effect of Prior Aspirin Use on Stroke Severity in the Trial of Org 10172 in Acute Stroke Treatment (TOAST) Stroke, December 1, 2001; 32(12): 2836 - 2840. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Scrutinio, C. Cimminiello, E. Marubini, M. Vittoria Pitzalis, M. Di Biase, P. Rizzon, and the STAMI Group Ticlopidine versus aspirin after myocardial infarction (stami) trial J. Am. Coll. Cardiol., April 1, 2001; 37(5): 1259 - 1265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kennon, C. P. Price, P. G. Mills, K. Ranjadayalan, J. Cooper, H. Clarke, and A. D. Timmis The effect of aspirin on C-reactive protein as a marker of risk in unstable angina J. Am. Coll. Cardiol., April 1, 2001; 37(5): 1266 - 1270. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T W Meade and P J Brennan Determination of who may derive most benefit from aspirin in primary prevention: subgroup results from a randomised controlled trial BMJ, July 1, 2000; 321(7252): 13 - 17. [Abstract] [Full Text]
|
|
|
|
 |
|
 S Kennon, K Barakat, A Suliman, P K MacCallum, K Ranjadayalan, P Wilkinson, and A D Timmis Influence of previous aspirin treatment and smoking on the electrocardiographic manifestations of injury in acute myocardial infarction Heart, July 1, 2000; 84(1): 41 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. S. Wong Risk Factors for Early Death in Acute Ischemic Stroke and Intracerebral Hemorrhage : A Prospective Hospital-Based Study in Asia Stroke, November 1, 1999; 30(11): 2326 - 2330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kennon, A. Suliman, P. K. MacCallum, K. Ranjadayalan, P. Wilkinson, and A. D. Timmis Clinical characteristics determining the mode of presentation in patients with acute coronary syndromes J. Am. Coll. Cardiol., December 1, 1998; 32(7): 2018 - 2022. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. G. Frederick, O. D. Suleymanov, J. A. Szalony, B. B. Taite, A. K. Salyers, L. W. King, L. P. Feigen, and N. S. Nicholson Protective Effect of Oral Xemilofiban in Arterial Thrombosis in Dogs : Increased Activity in Combination With Aspirin Circulation, August 25, 1998; 98(8): 813 - 820. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Smith Jr Risk-Reduction Therapy: The Challenge to Change : Presented at the 68th Scientific Sessions of the American Heart Association November 13, 1995 Anaheim, California Circulation, June 15, 1996; 93(12): 2205 - 2211. [Full Text]
|
|